Lee MS - Search Results

1

Improvement of overall and failure-free survival in stage IV follicular lymphoma: 25 years of treatment experience at The University of Texas M.D. Anderson Cancer Center.

Liu Q, Fayad L, Cabanillas F, Hagemeister FB, Ayers GD, Hess M, Romaguera J, Rodriguez MA, Tsimberidou AM, Verstovsek S, Younes A, Pro B, Lee MS, Ayala A, McLaughlin P. Liu Q, et al. Among authors: lee ms. J Clin Oncol. 2006 Apr 1;24(10):1582-9. doi: 10.1200/JCO.2005.03.3696. J Clin Oncol. 2006. PMID: 16575009

2

Fludarabine, mitoxantrone, dexamethasone (FND) compared with an alternating triple therapy (ATT) regimen in patients with stage IV indolent lymphoma.

Tsimberidou AM, McLaughlin P, Younes A, Rodriguez MA, Hagemeister FB, Sarris A, Romaguera J, Hess M, Smith TL, Yang Y, Ayala A, Preti A, Lee MS, Cabanillas F. Tsimberidou AM, et al. Among authors: lee ms. Blood. 2002 Dec 15;100(13):4351-7. doi: 10.1182/blood-2001-12-0269. Epub 2002 Aug 8. Blood. 2002. PMID: 12393618 Free article. Clinical Trial.

3

Intensive conventional-dose chemotherapy for stage IV low-grade lymphoma: high remission rates and reversion to negative of peripheral blood bcl-2 rearrangement.

McLaughlin P, Hagemeister FB, Swan F, Cabanillas F, Romaguera J, Rodriguez MA, Lee MS, Pate O, Sarris A, Younes A. McLaughlin P, et al. Among authors: lee ms. Ann Oncol. 1994;5 Suppl 2:73-7. doi: 10.1093/annonc/5.suppl_2.s73. Ann Oncol. 1994. PMID: 7515650 Clinical Trial.

4

The clinical significance of molecular response in indolent follicular lymphomas.

López-Guillermo A, Cabanillas F, McLaughlin P, Smith T, Hagemeister F, Rodríguez MA, Romaguera JE, Younes A, Sarris AH, Preti HA, Pugh W, Lee MS. López-Guillermo A, et al. Among authors: lee ms. Blood. 1998 Apr 15;91(8):2955-60. Blood. 1998. PMID: 9531606 Free article.

5

Correlation of bcl-2 rearrangement with clinical characteristics and outcome in indolent follicular lymphoma.

López-Guillermo A, Cabanillas F, McDonnell TI, McLaughlin P, Smith T, Pugh W, Hagemeister F, Rodríguez MA, Romaguera JE, Younes A, Sarris AH, Preti HA, Lee MS. López-Guillermo A, et al. Among authors: lee ms. Blood. 1999 May 1;93(9):3081-7. Blood. 1999. PMID: 10216105 Free article.

6

Molecular response assessed by PCR is the most important factor predicting failure-free survival in indolent follicular lymphoma: update of the MDACC series.

López-Guillermo A, Cabanillas F, McLaughlin P, Smith T, Hagemeister F, Rodríguez MA, Romaguera JE, Younes A, Sarris AH, Preti HA, Pugh W, Lee MS. López-Guillermo A, et al. Among authors: lee ms. Ann Oncol. 2000;11 Suppl 1:137-40. Ann Oncol. 2000. PMID: 10707796 Clinical Trial.

7

Safety of fludarabine, mitoxantrone, and dexamethasone combined with rituximab in the treatment of stage IV indolent lymphoma.

McLaughlin P, Hagemeister FB, Rodriguez MA, Sarris AH, Pate O, Younes A, Lee MS, Dang NH, Romaguera JE, Preti AH, McAda N, Cabanillas F. McLaughlin P, et al. Among authors: lee ms. Semin Oncol. 2000 Dec;27(6 Suppl 12):37-41. Semin Oncol. 2000. PMID: 11225999 Clinical Trial.

8

Molecular response of follicular lymphoma to cyclophosphamide, doxorubicin, vincristine, prednisone C(H)OP or COP-based therapy as measured by polymerase chain reaction evidence of translocation (14;18)(q32;q21).

Ha CS, Lee MS, McLaughlin P, Tucker SL, Wilder RB, Cox JD, Cabanillas F. Ha CS, et al. Among authors: lee ms. Cancer J. 2004 Jan-Feb;10(1):49-53. doi: 10.1097/00130404-200401000-00010. Cancer J. 2004. PMID: 15000495

9

Polymerase chain reaction monitoring for bcl-2 can be a dependable test under the right conditions.

Cabanillas F, Lee MS. Cabanillas F, et al. Among authors: lee ms. J Clin Oncol. 1995 Mar;13(3):795-6. doi: 10.1200/JCO.1995.13.3.795. J Clin Oncol. 1995. PMID: 7884438 No abstract available.

10

Serial determination of the bcl-2 gene in the bone marrow and peripheral blood after central lymphatic irradiation for stages I-III follicular lymphoma: a preliminary report.

Ha CS, Cabanillas F, Lee MS, Besa PC, McLaughlin P, Cox JD. Ha CS, et al. Among authors: lee ms. Clin Cancer Res. 1997 Feb;3(2):215-9. Clin Cancer Res. 1997. PMID: 9815675 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

6,006 results

Search Page